DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,224,560 | -54.0% | 21,769 | -51.7% | 0.34% | -57.4% |
| Q1 2023 | $11,350,621 | +87.9% | 45,035 | +97.8% | 0.80% | +85.5% |
| Q4 2022 | $6,041,755 | +86.0% | 22,763 | +77.6% | 0.43% | +44.8% |
| Q2 2022 | $3,249,000 | -22.1% | 12,818 | +1.1% | 0.30% | -11.5% |
| Q4 2021 | $4,173,000 | -25.0% | 12,684 | -30.6% | 0.34% | -17.0% |
| Q3 2021 | $5,564,000 | +29.8% | 18,277 | +14.4% | 0.41% | +20.8% |
| Q2 2021 | $4,288,000 | -56.1% | 15,982 | -63.6% | 0.34% | -66.8% |
| Q4 2020 | $9,760,000 | +523.6% | 43,938 | +288.4% | 1.01% | -0.6% |
| Q1 2020 | $1,565,000 | -66.6% | 11,312 | -76.2% | 1.02% | +219.7% |
| Q2 2018 | $4,685,000 | -11.7% | 47,478 | -12.4% | 0.32% | -30.2% |
| Q1 2018 | $5,304,000 | -3.9% | 54,177 | -8.9% | 0.46% | -10.6% |
| Q4 2017 | $5,517,000 | -5.3% | 59,445 | -12.5% | 0.51% | -8.4% |
| Q3 2017 | $5,824,000 | -10.2% | 67,903 | -11.6% | 0.56% | -8.7% |
| Q2 2017 | $6,484,000 | +332.3% | 76,838 | +338.1% | 0.61% | +289.2% |
| Q1 2017 | $1,500,000 | -39.3% | 17,540 | -44.8% | 0.16% | -42.7% |
| Q4 2016 | $2,471,000 | +12.0% | 31,753 | +33.6% | 0.27% | -27.7% |
| Q4 2015 | $2,207,000 | -33.6% | 23,767 | -39.1% | 0.38% | -34.7% |
| Q3 2015 | $3,324,000 | +98.2% | 39,021 | +97.5% | 0.58% | +39.8% |
| Q1 2015 | $1,677,000 | +144.5% | 19,762 | +146.9% | 0.42% | +88.6% |
| Q4 2014 | $686,000 | -38.3% | 8,005 | -43.3% | 0.22% | +25.0% |
| Q2 2014 | $1,112,000 | -10.9% | 14,125 | -15.2% | 0.18% | -40.1% |
| Q1 2014 | $1,248,000 | +754.8% | 16,653 | +776.5% | 0.29% | +314.1% |
| Q4 2013 | $146,000 | – | 1,900 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |